1. Home
  2. NTWK vs STTK Comparison

NTWK vs STTK Comparison

Compare NTWK & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • STTK
  • Stock Information
  • Founded
  • NTWK 1997
  • STTK 2016
  • Country
  • NTWK United States
  • STTK United States
  • Employees
  • NTWK N/A
  • STTK N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • STTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • STTK Health Care
  • Exchange
  • NTWK Nasdaq
  • STTK Nasdaq
  • Market Cap
  • NTWK 33.8M
  • STTK 37.6M
  • IPO Year
  • NTWK 1998
  • STTK 2020
  • Fundamental
  • Price
  • NTWK $3.21
  • STTK $0.83
  • Analyst Decision
  • NTWK
  • STTK Hold
  • Analyst Count
  • NTWK 0
  • STTK 4
  • Target Price
  • NTWK N/A
  • STTK $3.00
  • AVG Volume (30 Days)
  • NTWK 10.9K
  • STTK 385.8K
  • Earning Date
  • NTWK 05-14-2025
  • STTK 07-31-2025
  • Dividend Yield
  • NTWK N/A
  • STTK N/A
  • EPS Growth
  • NTWK N/A
  • STTK N/A
  • EPS
  • NTWK 0.02
  • STTK N/A
  • Revenue
  • NTWK $64,127,568.00
  • STTK $4,606,000.00
  • Revenue This Year
  • NTWK N/A
  • STTK N/A
  • Revenue Next Year
  • NTWK N/A
  • STTK N/A
  • P/E Ratio
  • NTWK $145.53
  • STTK N/A
  • Revenue Growth
  • NTWK 9.18
  • STTK 69.65
  • 52 Week Low
  • NTWK $2.14
  • STTK $0.69
  • 52 Week High
  • NTWK $3.34
  • STTK $4.99
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 76.52
  • STTK 35.84
  • Support Level
  • NTWK $2.83
  • STTK $0.77
  • Resistance Level
  • NTWK $2.98
  • STTK $1.14
  • Average True Range (ATR)
  • NTWK 0.09
  • STTK 0.08
  • MACD
  • NTWK 0.02
  • STTK -0.03
  • Stochastic Oscillator
  • NTWK 100.00
  • STTK 6.20

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: